| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |